Evaluation of the Safety of Recombinant Zoster Vaccine on Patients with Systemic Lupus Erythematosus in a Tertiary Hospital in Saudi Arabia: A Retrospective Single Centre Study. (PubMed, Mediterr J Rheumatol) - Sep 19, 2026 - "A subset of patients was treated with biological therapies, including Belimumab, Rituximab, and Anifrolumab. Vaccination with RZV in patients with SLE is safe and not associated with increased SLE activity which is comparable with unvaccinated patients. The reported side effects were mild and comparable to those of the general population."
Journal • Retrospective data • Herpes Zoster • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus • Varicella Zoster
|
|
Assia S Alwabel; Hoda Draz; Ibrahim Al-Homood; Nada Ibrahim
|